Original Research
Published on 15 Jun 2022
A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy Adults
in Drug Metabolism and Transport
- 2,056 views
- 2 citations
Original Research
Published on 15 Jun 2022
in Drug Metabolism and Transport
Original Research
Published on 14 Jun 2022
in Drug Metabolism and Transport
Original Research
Published on 10 Jun 2022
in Drug Metabolism and Transport
Original Research
Published on 08 Jun 2022
in Drug Metabolism and Transport
Original Research
Published on 03 Jun 2022
in Drug Metabolism and Transport
Original Research
Published on 30 May 2022
in Drug Metabolism and Transport
Original Research
Published on 26 May 2022
in Drug Metabolism and Transport
Original Research
Published on 25 May 2022
in Drug Metabolism and Transport
Original Research
Published on 25 May 2022
in Drug Metabolism and Transport
Original Research
Published on 20 May 2022
in Drug Metabolism and Transport
Original Research
Published on 20 May 2022
in Drug Metabolism and Transport
Clinical Trial
Published on 19 May 2022
in Drug Metabolism and Transport
Original Research
Published on 18 May 2022
in Drug Metabolism and Transport
Original Research
Published on 12 May 2022
in Drug Metabolism and Transport
Original Research
Published on 12 May 2022
in Drug Metabolism and Transport
Original Research
Published on 10 May 2022
in Drug Metabolism and Transport